Canadian Pfizer partner sues Arbutus Biopharma over COVID-19 vaccine patent - National | Globalnews.ca

vaccine sued Arbutus Biopharma Corp ABUS.O in Manhattan federal court on Friday, seeking to head off claims that the vaccine infringes Arbutus’ patents.

Canada-based Acuitas Therapeutics Inc said Arbutus and partner Genevant Sciences have threatened to sue for potentially billions of dollars in “unjustified royalties” over the vaccine Pfizer developed with Germany’s BioNTech SE BNTX.O.Acuitas asked the court to find that the Pfizer/BioNTech vaccine does not infringe Arbutus patents and that several Arbutus patents are invalid.

A representative for Arbutus did not immediately respond to a request for comment on Acuitas’ claims.Acuitas Chief Executive Thomas Madden said in a statement that the company remains confident in its technology but otherwise declined to comment on the lawsuit.

Technology Technology Latest News, Technology Technology Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Canadian Pfizer partner sues to head off patent lawsuit over COVID-19 vaccineThe Canadian biotech company that makes mRNA-delivery technology for Pfizer's COVID-19 vaccine sued Arbutus Biopharma in U.S. federal court, seeking to head off claims that the vaccine infringes Arbutus' patents.
Source: CTVNews - 🏆 1. / 99 Read more »

Canadian Pfizer partner sues to head off patent lawsuit over COVID-19 vaccineThe Canadian biotech company that makes mRNA-delivery technology for Pfizer's COVID-19 vaccine sued Arbutus Biopharma in U.S. federal court, seeking to head off claims that the vaccine infringes Arbutus' patents.
Source: CTVNews - 🏆 1. / 99 Read more »